Literature DB >> 16707759

Trastuzumab treatment in breast cancer.

Filippo Montemurro, Giorgio Valabrega, Massimo Aglietta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707759     DOI: 10.1056/NEJMc060852

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Molecular tumor board: the University of California-San Diego Moores Cancer Center experience.

Authors:  Maria Schwaederle; Barbara A Parker; Richard B Schwab; Paul T Fanta; Sarah G Boles; Gregory A Daniels; Lyudmila A Bazhenova; Rupa Subramanian; Alice C Coutinho; Haydee Ojeda-Fournier; Brian Datnow; Nicholas J Webster; Scott M Lippman; Razelle Kurzrock
Journal:  Oncologist       Date:  2014-05-05

Review 2.  Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.

Authors:  Maria Schwaederle; Melissa Zhao; J Jack Lee; Alexander M Eggermont; Richard L Schilsky; John Mendelsohn; Vladimir Lazar; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

3.  Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.

Authors:  Kristina W Thiel; Luiza I Hernandez; Justin P Dassie; William H Thiel; Xiuying Liu; Katie R Stockdale; Alissa M Rothman; Frank J Hernandez; James O McNamara; Paloma H Giangrande
Journal:  Nucleic Acids Res       Date:  2012-03-30       Impact factor: 16.971

4.  Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions.

Authors:  Alexander Pearlman; Mohammed Tanjimur Rahman; Kinnari Upadhyay; Johnny Loke; Harry Ostrer
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

5.  Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.

Authors:  Kyrollis Attalla; Renzo G DiNatale; Phillip M Rappold; Christopher J Fong; Francisco Sanchez-Vega; Andrew W Silagy; Stanley Weng; Jonathan Coleman; Chung-Han Lee; Maria I Carlo; Jeremy C Durack; Stephen B Solomon; Victor E Reuter; Paul Russo; Timothy A Chan; Robert J Motzer; Nikolaus D Schultz; Ed Reznik; Martin H Voss; A Ari Hakimi
Journal:  Clin Cancer Res       Date:  2021-07-14       Impact factor: 12.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.